The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

All Americans can order free COVID-19 tests by mail starting Thursday, the Biden administration announced. Households will be ...

Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain up to four free COVID-19 tests through the U.S. Department of Health and ...

Vaccines have to meet high effectiveness and safety standards before they are offered to the public and continue to maintain a good ongoing safety record. In Aotearoa New Zealand (NZ) Medsafe has a ...

Pfizer and its partner, BioNTech, sued Moderna in London in September 2022, seeking to revoke two patents held by Moderna, ...

Firms faced off at two trials in London earlier this year centred on the use of messenger RNA (mRNA) technology in ...

Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the ...

OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. | ...

A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. In July, a High Court judge delivered a mixed ...

In July, a High Court judge delivered a mixed ruling in the long-running dispute that has pitted pharmaceutical giant Pfizer Inc and German drug manufacturer BioNTech SE, against Cambridge, ...